Global transcatheter aortic valve replacement market, size, share, market intelligence, company profiles, market trends, strategy, research and analysis report by approach (transfemoral, transapical and transaortic approach) forecast 2018-2023 Transcatheter aortic valve replacement (TAVR) is the implantation of the aortic valve in the heart through the blood vessels unlike in case of valve replacement as done in open heart surgery. Rising valvular diseases and increasing prevalence of aortic stenosis has been the major factor driving the market growth. According to the American Heart Association, in the US, more than 80,000 aortic valve replacement procedures are performed every year which shows the demand for heart valve implantation. Additionally, the TAVR has been approved by the regulatory bodies and are available for patients receiving Medicaid and Medicare facilities. Such reimbursement policies further motivate the growth of the global TAVR market.